跳至主要内容
临床试验/RBR-5vzynf3
RBR-5vzynf3已完成1 期

se of homeopathic therapy during the covid-19 pandemic in health units in Rio de Janeiro

Faculdade de Farmácia da Universidade Federal do Rio de Janeiro0 个研究点开始时间: 2023年3月29日最近更新:

试验速览

阶段
1 期
状态
已完成
发起方

研究概览

简要总结

Data from 51 families (128 participants) were analyzed and showed no statistically significant difference related to the severity of illness in the previous sick and health groups. Although, the secondary outcome showed that a high percentage of the participants (98.03%) reported having had general health symptoms' improvements (84.31%) and none reported adverse events. Despite the previous comorbidities in 52.9% of the families and considering that Covid-19 infected 1.96% of them, only 0.098% looked for medical assistance and none needed hospitalization.

研究设计

研究类型
Interventional

入排标准

年龄范围
18Y 至 0(—)

入选标准

  • Women and men aged 18 years or older with or not COVID-19 influenza-like symptoms were included in this study

排除标准

  • The exclusion criterion was a severe acute respiratory syndrome that leads to hospitalization by primary care teams

研究者

发起方
Faculdade de Farmácia da Universidade Federal do Rio de Janeiro

相似试验